Mercer University Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
1997
NCT00003054
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Alternative names

Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center | Mercer University School of Medicine

Active Ingredients

Drugs in Phase 4 Trials (5)

abacavir (ziagen) (1 trial)

calcium (1 trial)

fosamprenavir (lexiva) (1 trial)

lamivudine (epivir) (1 trial)

ritonavir (Norvir) (1 trial)

Drugs in Phase 2 Trials (1)

paclitaxel (taxol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leiomyosarcoma (Phase 2)

Sarcoma (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 6